Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: opalapril who wrote (10873)	7/22/1999 3:29:00 PM
From: aknahow	Read Replies (1) \| Respond to of 17367

The idea that XOMA disappears if the P III trial is not a success is in error. We will disappear, and only wish it had, rather than ourselves. I don't want to belabor the point, as I proceed to do so, but BPI and LBP have had hundreds of research papers written about them. The interest in these proteins is not going to cease if it is found that BPI does not provide any significant advantage in curing Meningococcemia.